Home  >  News
Eppen_Himac_Jan25
Waters_Ebook_Dec24
you can get e-magazine links on WhatsApp. Click here
News
  Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection,   January 24, 2025
  EMA committee approves Sanofi’s anti-CD38 therapy, Sarclisa in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma,   January 23, 2025
  Junshi Biosciences enters distribution and marketing partnership with LEO Pharma for toripalimab in Europe,   January 22, 2025
  Glenmark launches phytonadione injectable emulsion USP, 10 mg/mL single dose ampules,   January 21, 2025
  Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for Twymeeg achieving JPY 5 billion net sales in Japan,   January 21, 2025
  UK MHRA grants marketing authorization to Idorsia Pharma’s aprocitentan to treat adults with hypertension whose blood pressure cannot be controlled by other medications,   January 20, 2025
  China NMPA grants marketing authorization to IMPACT Therapeutics’ Senaparib for 1L maintenance therapy in ovarian cancer,   January 18, 2025
  In 2024 EMA recommends 114 medicines for marketing authorisation; 46 had a new active substance,   January 18, 2025
  Telix Pharma’s prostate cancer PET1 imaging agent, Illuccix receives European marketing approval,   January 18, 2025
  Handa Therapeutics acquires US FDA approved chronic myeloid leukaemia drug, Phyrago tablets from Nanocopoeia,   January 17, 2025
  InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome,   January 17, 2025
  Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome,   January 16, 2025
  Chugai Pharma to transfer future marketing of anti-cancer agent, Tarceva tablets 25, 100 & 150 in Japan to Cheplapharm,   January 15, 2025
  Telix enters agreement with Curium Pharma for transfer of marketing and distribution rights for Scintimun,   January 14, 2025
  Teva inks strategic collaboration with Klinge & Formycon to commercialize Formycon’s biosimilar candidate to Eylea in major parts of Europe and Israel,   January 14, 2025
  Lupin introduces Minzoya in US market,   January 13, 2025
  Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner,   January 10, 2025
  Norgine submits MAA to EMA for eflornithine in high-risk neuroblastoma,   January 08, 2025
  Bayer seeks China NMPA marketing authorization for ARi darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer,   January 08, 2025
  Santhera enters supply and distribution agreement with Clinigen Group for Agamree to treat patients with Duchenne muscular dystrophy,   January 07, 2025

 Back
 
Asia_Lab_Expo2025
chemexpoindia
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram